Introduction
Mitral regurgitation (MR) quantification remains challenging: two-dimensional echocardiography using proximal isovelocity surface area (PISA) has shown to underestimate mitral regurgitant volume (RVol) compared with three-dimensional imaging techniques. [1] [2] [3] Twodimensional PISA estimates the effective regurgitant orifice area (ROA) by multiplying the surface of the hemisphere of the flow convergence zone of the regurgitant jet proximal to the orifice and the velocity of aliasing divided by the peak velocity of the regurgitant jet. However, this calculation considers the regurgitant orifice as circular. In contrast, three-dimensional echocardiography permits the 'en face' view of the mitral regurgitant orifice thereby providing the anatomical ROA. By introducing the anatomic ROA into the equation, the assumption of being the regurgitant orifice circular is avoided, reducing the estimating error to calculate the RVol. Several studies have shown better agreement to grade MR between three-dimensional echocardiography and cardiac magnetic resonance compared with two-dimensional echocardiography. [1] [2] [3] A subgroup of patients in whom grading MR can be challenging, and may have important clinical implications, is the group of patients with severe aortic stenosis. The development of new transcatheter therapies to reduce MR has enabled additional therapeutic options to improve the outcome of these patients. Multi-detector row computed tomography (MDCT) plays a central role in the patient selection for transcatheter aortic valve implantation (TAVI). In patients with concomitant MR, the anatomic ROA of the mitral valve can be measured during the systolic MDCT phase. Combining Doppler echocardiographic data and the anatomic ROA of the mitral valve, the RVol can be calculated. The aim of this study was to evaluate the feasibility of integrating MDCT and echocardiography data to derive the integrated mitral RVol and to assess the impact on reclassification of MR severity.
Methods Patients
Patients with severe aortic stenosis who underwent pre-TAVI dynamic MDCT and had any grade of MR were evaluated. Patients with previous mitral valve repair or replacement were excluded. After excluding 14 patients with insufficient quality of the MDCT data during the systolic phase to analyse the mitral ROA, 73 patients were included in this analysis. MR was classified as primary, if the regurgitation was caused by morphological changes of the mitral leaflets or annulus, or as secondary if macroscopic mitral valve abnormalities were absent and the regurgitation resulted from global and/or regional left ventricular (LV) remodelling. 4 Clinical echocardiographic and MDCT data were prospectively collected in the departmental electronic clinical files (EPD vision version 11.3.26.0; Leiden, The Netherlands) and retrospectively analysed. The Institutional Review Board approved this retrospective analysis of clinically acquired data and waived the need of patient written informed consent.
Transthoracic echocardiography
Two-dimensional and colour Doppler transthoracic echocardiographic data were acquired with commercially available ultrasound systems equipped with M5S transducers (E9 systems; General Electric Vingmed, Horten, Norway). Parasternal (long-and short-axis) and apical (2-, 3-, and 4-chamber) views were acquired with the patients in the left lateral decubitus position and subcostal views with the patients in supine position. The data were stored in cine-loop format in the departmental echocardiographic database enabling off-line analysis (EchoPac 112.0.1; GE Medical Systems, Horten, Norway). The transthoracic echocardiogram performed closer to the date of the MDCT was selected [median time between MDCT and echocardiography was 16 (interquartile range 3-57) days]. From the apical two-and four-chamber views, LV ejection fraction was quantified using the Simpson's biplane method. 5 According to current guidelines, the severity of MR was quantitatively graded using a multiparametric approach which includes structural parameters (left atrium and LV dimensions, aspect of the leaflets and subvalvular apparatus), continuous wave Doppler jet density and contour, upstream pulmonary vein flow, vena contracta width, and effective ROA and the RVol as assessed with the PISA method ( Figure 1 ). 4 The RVol was assessed by multiplying the effective ROA by the velocity time integral (VTI) of the regurgitant jet from the continuous wave Doppler images (Figure 1 ). 4 For patients with primary MR, severe MR was defined as an RVol of > _60 mL/ beat whereas for patients with secondary MR, severe MR was defined as an RVol of > _30 mL/beat. 4 Multi-detector row computed tomography data acquisition
The MDCT data were acquired using a volumetric 320-slice MDCT scanner (AquilionOne; Toshiba Medical Systems, Tochigi-ken, Japan) with a collimation of 320 Â 0.5 mm and a rotation time of 350 ms. Tube voltages and currents varied from 100 to 135 kV and from 200 to 580 mA, depending on the patient's body mass index. 6 Initially, according to the institutional acquisition protocol, oral b-blockers were administered to patients with heart rates >65 b.p.m. after evaluation of the patient's haemodynamic condition (n = 13). However, for the majority of TAVI patients included in the present evaluation, b-blockers were not administered. Based on patient's body weight, 60-100 mL of ionic contrast medium (Ultravist 370; Bayer, Whippany, NJ, USA) was intravenously administered in three phases: first 60-80 mL of contrast material (flow-rate 5.0-6.0 mL/s), followed by a 1:1 mixture of contrast and saline and additional 25 mL of saline (flow-rate 3.0 mL/s). Triggering of the scan was synchronized with arrival of the contrast material in the left ventricle by using automated peak enhancement detection (threshold of þ180 Hounsfield Units). The heart was scanned in a single volume of 16 cm. The entire cardiac cycle was prospectively scanned, triggered to simultaneous electrocardiogram registration. MDCT data were reconstructed at each 10% of the RR interval and subsequently transferred to an external workstation (Vitrea 2; Vital Images, Plymouth, MN, USA) for off-line image analysis.
Multi-detector row computed tomography data analysis
Multi-detector row computed tomography analyses were performed by two experienced observers. The systolic phases were evaluated to select the phase with the smaller LV volume. Using three multiplanar reformation planes, the two-and four-chamber views were reconstructed and aligned to obtain the double oblique plane that transected the narrowest mitral regurgitant orifice ( Figure 1 ). At that level, the mitral ROA was measured by planimetry ( Figure 1 ).
Integration of Doppler haemodynamics with multi-detector row computed tomography anatomic data
To calculate the integrated RVol, the VTI of the regurgitant jet measured on continuous wave Doppler data is multiplied by the anatomical ROA measured on MDCT following the formula: Integrated RVol ¼ MDCT mitral ROA Â VTI: An example of the calculation of the integrated RVol of MR is demonstrated in Figure 1 .
Statistical analysis
Continuous data are presented as mean ± standard deviation and categorical data as frequencies and percentages. Differences in the haemodynamic and anatomical analysis of MR between patients with primary MR and patients with secondary MR were analysed using the unpaired Student's t-test. MDCT mitral ROA measurements was analysed with repeated measurements by one observer at two different time points and by the second observer blinded to the measurements of the first observer. Intra-and inter-observer agreements were analysed using BlandAltman analysis and intra-class correlation coefficients (two-way mixed model). Statistical analyses were performed with the SPSS software (IBM Corp., Armonk, NY, USA).
Results
Clinical characteristics of the 73 patients are summarized in Table 1 . Primary MR was present in 28 patients (38.4%) and secondary MR in 45 (61.6%). The results of the haemodynamic, anatomical, and integrated analysis of MR for the overall population and for the subgroups of primary and secondary MR are presented in Table 2 . The average heart rate during echocardiography was 76 ± 15 b.p.m. and during MDCT scanning 70 ± 16 b.p.m. (P = 0.002). There were no differences in systolic and diastolic blood pressure before echocardiography (132 ± 21 and 70 ± 13 mmHg, respectively) and before the MDCT (131 ± 24 and 67 ± 11 mmHg, respectively; P = 0.552).
In the overall population, the mean effective ROA and RVol of MR on echocardiography were 13.3 ± 8.2 mm 2 and 23.9 ± 13.6 mL/beat, respectively. In the overall population, MDCT analysis showed a mean mitral ROA of 11.3 ± 7.4 mm 2 , resulting in a mean integrated RVol of 21.4 ± 14.7 mL/beat. The mean values of echocardiographic effective ROA and RVol and MDCT-derived mitral ROA and integrated RVol were not statistically different between patients with primary and secondary MR ( Table 2 ). 
Reclassification of severe mitral regurgitation according to integrated mitral regurgitant volume
Based on two-dimensional echocardiographic PISA, 12 patients had severe MR: 10 patients with secondary MR and two patients with primary MR. By using the integrated mitral RVol, seven patients (10%) would have been reclassified to non-severe MR: five patients with secondary MR and two patients with primary MR. In contrast, according to echocardiographic RVol of MR, 61 patients had nonsevere MR of which 10 (14%) patients, all with secondary MR, would have been reclassified to severe MR according to the integrated mitral RVol (Figure 2) .
Reproducibility data
The intra-and inter-observer variabilities for the measurement of the mitral ROA on MDCT were assessed in 15 patients. For intraobserver variability, the respective mean bias and intra-class correlation coefficient were 0.67 ± 3.43 mm 2 (95% limits of agreement: -6.07 to 7.40) and 0.87 (95% confidence interval: 0.65-0.95), respectively. For inter-observer variability, the mean bias and intra-class coefficient were 0.73 ± 3.40 mm 2 (95% limits of agreement: -5.87 to 7.34) and 0.85 (95% confidence interval: 0.62-0.95), respectively ( Figure 3) .
Discussion
This study showed the proof-of-concept of integrating Doppler echocardiographic data and MDCT-derived mitral anatomical ROA for the assessment of the integrated mitral RVol and grading of MR severity. In patients with severe aortic stenosis and concomitant MR, the use of integrated mitral RVol resulted in reclassification of MR grade, with 7 of 73 patients being reclassified from severe MR (based on echocardiography) to non-severe MR, and 10 of 73 patients from non-severe MR to severe MR.
Mitral regurgitation in patients undergoing transcatheter aortic valve replacement
Significant (moderate or severe) MR is relatively frequent in patients with severe aortic stenosis undergoing TAVI. The reported prevalence of significant MR in TAVI patients varies from 19% to 33%. This wide range may be partly explained by differences in the methodology used for MR grading. 7, 8 In patients with aortic stenosis, accurate MR grading is challenging. The high LV pressure afterload may lead to overestimation of the MR severity if grading is based qualitatively on colour flow Doppler. This emphasizes the need for a more quantitative analysis of MR, based on vena contracta measurement and based on the PISA method to assess the mitral effective ROA and the RVol. 4 Nevertheless, an important limitation of the twodimensional PISA method is the assumption of a circular regurgitant orifice. Direct visualization of the anatomic ROA using three-dimensional echocardiography has demonstrated that its shape is rather elongated and semi-lunar in patients with functional MR. 2,3 A recent review of clinical studies including 446 patients with MR showed that two-dimensional echocardiography tended to underestimate the effective ROA and RVol of functional MR compared with three-dimensional echocardiography. 3 In patients referred for TAVI, the use of two-dimensional PISA method to quantify the effective ROA and the RVol may be problematic because the aetiology of MR is usually functional and the assumption of a circular regurgitant orifice may lead to underestimation of the effective ROA. 8 In this study, 61.6% of the patients had functional MR and 16% had significant MR based on two-dimensional echocardiographic quantitative measurements.
Integrated regurgitant volume of mitral regurgitation
To overcome the relative inaccuracy of two-dimensional echocardiography in grading MR in TAVI patients, MDCT (which is extensively used in patient selection and procedural planning) may be of help. Similar to three-dimensional echocardiography, MDCT provides volume-rendered images of the mitral valve that can be aligned parallel to the mitral regurgitant orifice enabling an en face view for direct assessment of the anatomic ROA. 9, 10 Incorporation of the true crosssectional area of the mitral regurgitant orifice into the formula to calculate the mitral RVol avoids geometrical assumptions of the ROA. Compared with two-dimensional echocardiography, grading based on the integrated mitral RVol resulted in reclassification of 10% of the patients from severe MR to non-severe MR and 14% of the patients from non-severe MR to severe MR in this study.
The role of MDCT in the selection of patients and planning of TAVI is undisputed. Current recommendations advocate the acquisition of MDCT data in systole to measure the aortic annulus and size the prosthesis. 11 The anatomy and geometry of the mitral valve can be also assessed during the systolic phase. 12 Incorporating the true mitral ROA in the calculation of the integrated RVol may have important implications in this subgroup of patients. A recent metaanalysis including >8000 TAVI patients demonstrated that concomitant significant MR is associated with impaired early and late survival. 13 For patients with severe aortic valve stenosis and concomitant severe MR, double valve intervention is indicated despite the associated additional surgical risk compared with isolated aortic valve surgery. 14, 15 In contrast, in the vast majority of patients undergoing TAVI significant MR is currently left untreated. 8 Whether simultaneous or staged (if MR remains significant) transcatheter repair/replacement of the mitral valve is beneficial for TAVI patients with significant MR warrants future research and accurate grading of MR severity is the first step to refer these patients for additional intervention.
Limitations
This study proposed a new concept for MR grading by combining the true mitral anatomical ROA assessed with MDCT with echocardiographic Doppler flow data to quantify the integrated mitral RVol. The number of patients with significant MR is a limitation. In addition, the lack of a reference standard (particularly in vitro measurements) is another limitation. However, even if a head-to-head comparison between integrated MDCT with Doppler echocardiography data and three-dimensional echocardiography-based PISA quantification of the mitral RVol could have been performed, still a true reference standard to compare with and to determine the accuracy of this novel methodology to quantify mitral RVol would be lacking. Despite that all reconstructed systolic phases were evaluated to identify the largest mitral ROA with the minimum LV systolic volume, the temporal resolution of MDCT is lower than that of echocardiography which might be source of measurement error. Changes in loading conditions of the patients between the time of echocardiography and the time of MDCT scanning are an important limitation because this may influence MR severity. Nevertheless, patients were haemodynamically stable, without significant changes in blood pressure, between both imaging techniques. Furthermore, planimetry of the mitral ROA by MDCT is more challenging than with three-dimensional echocardiography due to the inability of MDCT to visualize the regurgitant flow. Therefore, integrated mitral RVol may represent a robust quantitative grading parameter of MR but should always be evaluated as part of a multiparametric approach.
Conclusions
Integrated mitral RVol is a quantitative parameter of MR grade that combines the true cross-sectional mitral ROA assessed with MDCT and Doppler mitral flow which resulted in a significant reclassification of MR grade in patients with severe aortic stenosis undergoing TAVI. 
